#insulin resistance

1 article

A clean, modern editorial flat-lay on a pale oat-colored linen surface, shot from slightly above in soft diffused natural window light. At the center sits an amber glass supplement bottle with a minimalist cream label, unbranded, with a few capsules spilling onto the fabric in soft greens and ivory tones. Around it are fresh botanical elements: a sprig of green tea leaves, sliced ginger root, a small bundle of dried hibiscus petals, and a few pale green pineapple and papaya slices hinting at digestive enzymes. A small ceramic bowl of creamy plain yogurt with a wooden spoon suggests probiotics. To the left, a flexible tailor's measuring tape in soft blush pink loosely curls across the linen, with a slim brushed-brass scale partly visible at the frame edge. On the right, a minimalist white notebook lies open with a hand-drawn simple line chart showing two diverging lines, one trending downward and one flat, with no readable text. A pair of reading glasses with thin gold frames rests beside it, and a tiny pair of balanced brass scales sits in the background, subtly suggesting weighing evidence and caution.

The palette is muted sage green, warm cream, soft terracotta, and touches of blush and brass. Shadows are gentle and long, the depth of field is shallow with a creamy blurred background, and the negative space on the left third of the frame leaves room for a headline overlay. The overall feel is a contemporary health and science journal, calm, trustworthy, and slightly skeptical, in the style of a premium wellness magazine photographed with a 50mm lens, with crisp texture on linen, glass, and botanicals.

Amestecul probiotic‑enzimatic SlimSEB a învins placebo – dar există o bănuială

BY DR. GYMBRO · 30 oct. 2026

Un amestec probiotic, enzimatic și botanic numit SlimSEB a depășit placebo în cadrul unui studiu randomizat de 12 săptămâni pe 87 de adulţi cu risc de diabet de tip 2. Participanţii obezi au pierdut cu 4,5 kg în plus față de placebo și și-au redus talia cu 11 cm, în timp ce colesterolul și rezistența la insulină s-au îmbunătățit. Produsul a fost furnizat de producător, studiul a fost mic și scurt, iar formula multi‑ingredientă nu permite atribuirea efectului unui singur component. Iată ce arată datele, cum se compară cu medicamentele GLP‑1 și cine ar trebui să privească cu scepticism acest supliment.